CLINICAL_TRIALS trial_result · 2017-03-10

Clinical Trial Update: Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults [Phase 1, Phase 2]

Phase 1/2 initial pilot study of peanut oral immunotherapy in adults with peanut allergy; the trial was terminated, and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of North Carolina, Chapel Hill | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-03-10